Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 179

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Effect of Colchicine on Myocardial Injury in Acute Myocardial Infarction

Open access
Mewton, Nathan, Roubille, François, Bresson, Didier, Prieur, Cyril, Bouleti, Claire, Bochaton, Thomas, Ivanes, Fabrice, Dubreuil, Olivier, Biere, Loïc, Hayek, Ahmad, Derimay, François, Akodad, Mariama, Alos, Benjamin, Haider, Lamis, El Jonhy, Naoual, Daw, Rachel, De Bourguignon, Charles, Dhelens, Carole, Finet, Gérard, Bonnefoy-Cudraz, Eric, Bidaux, Gabriel, Boutitie, Florent, Maucort-Boulch, Delphine, Croisille, Pierre, Rioufol, Gilles, Prunier, Fabrice, Angoulvant, Denis, on behalf of the COVERT-MI Study Investigators · 2021 · Circulation

Abstract

Background: Inflammation is a key factor of myocardial damage in reperfused ST-segment–elevation myocardial infarction. We hypothesized that colchicine, a potent anti-inflammatory agent, may reduce infarct size (IS) and left ventricular (LV) remodeling at the acute phase of ST-segment–elevation myocardial infarction. Methods: In this double-blind multicenter trial, we randomly assigned patients admitted for a first episode of ST-segment–elevation myocardial infarction referred for primary percutaneous coronary intervention to receive oral colchicine (2-mg loading dose followed by 0.5 mg twice a day) or matching placebo from admission to day 5. The primary efficacy outcome was IS determined by cardiac magnetic resonance imaging at 5 days. The relative LV end-diastolic volume change at 3 months and IS at 3 months assessed by cardiac magnetic resonance imaging were among the secondary outcomes. Results: We enrolled 192 patients, 101 in the colchicine group and 91 in the control group. At 5 days, the gadolinium enhancement–defined IS did not differ between the colchicine and placebo groups with a mean of 26 interquartile range (IQR) [16–44] versus 28.4 IQR [14–40] g of LV mass, respectively ( P =0.87). At 3 months follow-up, there was no significant difference in LV remodeling between the colchicine and placebo groups with a +2.4% (IQR, –8.3% to 11.1%) versus –1.1% (IQR, –8.0% to 9.9%) change in LV end-diastolic volume ( P =0.49). Infarct size at 3 months was also not significantly different between the colchicine and placebo groups (17 IQR [10–28] versus 18 IQR [10–27] g of LV mass, respectively; P =0.92). The incidence of gastrointestinal adverse events during the treatment period was greater with colchicine than with placebo (34% versus 11%, respectively; P =0.0002). Conclusions: In this randomized, placebo-controlled trial, oral administration of high-dose colchicine at the time of reperfusion and for 5 days did not reduce IS assessed by cardiac magnetic resonance imaging. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03156816.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.121.056177

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 179

Metadata

Authors
Mewton, N., Roubille, F., Bresson, D., Prieur, C., Bouleti, C., Bochaton, T., Ivanes, F., Dubreuil, O., Biere, L., Hayek, A., Derimay, F., Akodad, M., Alos, B., Haider, L., El Jonhy, N., Daw, R., De Bourguignon, C., Dhelens, C., Finet, G., Bonnefoy-Cudraz, E., Bidaux, G., Boutitie, F., Maucort-Boulch, D., Croisille, P., Rioufol, G., Prunier, F., Angoulvant, D., & on behalf of the COVERT-MI Study Investigators
Venue
Circulation
Published
2021-09-14
Volume
144
Issue
11
Pages
859-869
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W3194925641
Cited by
179
References
4
FWCI
14.90
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of Colchicine on Myocardial Injury in Acute Myocardial Infarction. https://app.cochat.ai/papers/10.1161/circulationaha.121.056177
The paper
Mewton, N., Roubille, F., Bresson, D., Prieur, C., Bouleti, C., Bochaton, T., Ivanes, F., Dubreuil, O., Biere, L., Hayek, A., Derimay, F., Akodad, M., Alos, B., Haider, L., El Jonhy, N., Daw, R., De Bourguignon, C., Dhelens, C., Finet, G., . . . on behalf of the COVERT-MI Study Investigators. (2021). Effect of Colchicine on Myocardial Injury in Acute Myocardial Infarction. Circulation. https://doi.org/10.1161/circulationaha.121.056177

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.